SCHEMBL3379620

SCHEMBL3379620

CCOC(=O)CCCCCCC(=O)c1ccco1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 2/20 0.45
ALOX5 P09917 1/20 0.45
TSHR P16473 2/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
GAA P10253 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 4/20 0.43
MAPT P10636 3/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
ABL1 P00519 1/20 0.43
F2 P00734 1/20 0.43
KMT2A Q03164 1/20 0.43
RIN1 Q13671 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6157657 0.89 ALDH1A1 (0.51) ALDH1A1CYP4F2CYP4A11NPC1RAB9A
SCHEMBL10352780 0.85 CES1 (0.52) ALDH1A1TSHRCES2CES1GAA
SCHEMBL18640578 0.83 ALDH1A1 (0.53) ALDH1A1NPC1TSHRGAAHTT
SCHEMBL18640576 0.83 ALDH1A1 (0.53) ALDH1A1NPC1TSHRGAAHTT
SCHEMBL25222615 0.83 GAA (0.59) ALDH1A1CES2CES1GAAHTT
SCHEMBL18825664 0.83 GAA (0.59) ALDH1A1CES2CES1GAAHTT
SCHEMBL5634680 0.83 GAA (0.59) ALDH1A1CES2CES1GAAHTT
SCHEMBL4382929 0.83 GAA (0.59) ALDH1A1CES2CES1GAAHTT
SCHEMBL10353082 0.83 GAA (0.59) ALDH1A1CES2CES1GAAHTT
SCHEMBL4373141 0.83 GAA (0.59) ALDH1A1CES2CES1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280764-B1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2010-11-24 EP disclosed
US-20090181971-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. 2009-07-16 US disclosed
US-7288567-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2007-10-30 US disclosed
EP-1524262-A1 Inhibitors of histone deacetylase Methylgene, Inc. (CA) 2005-04-20 EP disclosed
EP-1280764-A2 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2003-02-05 EP disclosed
US-20020115826-A1 Inhibitors of histone deacetylase 92229129 QUEBEC INC. (CA) 2002-08-22 US disclosed
WO-2001070675-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2001-09-27 WO disclosed
US-4076732-A Derivatives of α-(6-carboxyhexyl) furfuryl alcohol AMERICAN CYANAMID COMPANY (US) 1978-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115826-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 ALDH1A1 796/4885CYP4F2 4675/4885CYP4A11 4334/4885
US-20090181971-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC3 ALDH1A1 796/4885CYP4F2 4675/4885CYP4A11 4334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.